Novo Nordisk A/S (NVO) is near the top in its industry group according to InvestorsObserver. NVO gets an overall rating of 76. That means it scores higher than 76 percent of stocks. Novo Nordisk A/S gets a 93 rank in the Biotechnology industry. Biotechnology is number 51 out of 148 industries.
Click Here to get the full Stock Score Report on Novo Nordisk A/S (NVO) Stock.
What do These Ratings Mean?
Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 76 means the stock is more attractive than 76 percent of stocks.
These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.
What's Happening With Novo Nordisk A/S Stock Today?
Novo Nordisk A/S (NVO) stock is trading at $64.16 as of 11:03 AM on Wednesday, Feb 5, a rise of $2.57, or 4.17% from the previous closing price of $61.59. The stock has traded between $63.37 and $64.20 so far today. Volume today is 1,062,631 compared to average volume of 1,247,564.
